FDA
approval
· 2020-03-16
FDA Approved: AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
Summary
FDA approved Lupin's supplemental application for a generic fixed-dose combination of amlodipine, valsartan, and hydrochlorothiazide for the treatment of hypert…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE (AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE)